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The effect of Momordica charantia Extract (MCE), Centella asiatica Extract (CAE) and 
Morinda citrifolia Fruit Extract (MCFE) on lipoprotein lipase (LPL) activity, pancreatic 
lipase activity, proliferation and differentiation of 3T3-L1 preadipocytes were 
investigated to evaluate their potential application for obesity treatment. Dried plant 
samples were extracted in 99.5% ethanol. Extracts were analyzed for total phenolic 
compounds and flavonoids utilizing Folin Ciocalteau assay and HPLC respectively. The 
anti oxidative potential of all extracts were also evaluated using the FRAP and DPPH 
assays. The inhibitory effects of the extracts on lipoprotein lipase (LPL) and pancreatic 
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lipase (PL) were determined in vitro. The extent of cell proliferation was determined by 
cell viability assay and the degree of differentiation was measured by Oil Red O staining 
assay. Results of the study showed that all extracts tested consisted of excellent 
concentration of phenolics compounds, and catechin and epicatechin was predominantly 
present in all three extracts. All extracts also showed good anti oxidative potential in 
scavenging free radicals.  At a concentration of 1 mg/mL, the extracts inhibited LPL 
activity differently, with MCFE showing the highest inhibitory effect (21.4±2.3%), 
followed by CAE (16.3±1.1 %) and MCE (10.6 ±0.6%). At a concentration of 
0.02mg/ml, all three extracts inhibited PL, with CAE showing the highest inhibition 
(31.1%), followed by MCFE (29.7%) and lastly MCE (21.5 %), with no significance 
difference. MCE showed the highest inhibitory effect on both cell proliferation and 
differentiation of preadipocytes. After 72 hours, MCE was found to be most toxic with an 
LC50 of 1.6mg/L, followed by CAE with an LC50 of 2.4 mg/mL and MCFE had the least 
cytotoxic effect with LC50 of 4.5 mg/mL. Results after 48 hours of plating showed that 
MCE exhibited the highest inhibitory effect on differentiation in a dose dependent 
manner. The highest inhibition, 74.7 ±5.41% of control, occurred at concentration of 0.5 
mg/mL. Data from the study indicate that MCE exert potential anti obesity effects by 
inhibiting proliferation and differentiation of preadipocytes. MCFE can also be used as a 
therapeutic treatment for obesity due to its relatively high anti LPL and PL activity and 
low cytotoxic effect. 
 
Key words: Obesity, Momordica charantia, Morinda citrifolia, Centella asiatica, 3T3-
L1 cells, cell differentiation, Lipoprotein lipase, flavonoids, catechin and phenolic 
compounds. 
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Kesan exstrak Momordica charantia ( MCE), ekstrak Centella asiatica ( CAE) dan buah 
Morinda citrifolia ( MCFE) ke atas aktiviti lipase lipoprotein (LPL), aktiviti lipase 
pancreatic, pengandaan dan perbezaan 3T3-L1 preadipocytes tela dikaji untuk menilai 
potensi untuk rawatan kegemukan .Sampel tumbuhan yang telah dikeringkan telah 
diesktrak dalam 99.5 % etanol. Jumlah komponen fenolik/ flavonoids telah dianalisis 
mengunakan Kaedah Folin Ciocalteau dan HPLC. Keupayaan anti- pengoksidaan semua 
ekstrak juga dinilai meggunakan kaedah FRAP dan DPPH. Kesan pencegahan semua 
ekstak keatas LPL dan PL ditentukan secara in vitro. Tahap pengandaan sel telah 
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ditentukan oleh kaedah MTT dan darjah perbezaan diukur oleh assey Oil Red O staining. 
Keputusan daripada kajian menunjukkan semua ekstrak yang diuji mengandungi 
kepekatan komponen fenolik yang baik dan katekin dan epikatekin adalah paling 
dominan di antara kesemua ekstrak. Kesemua juga menunjukkan keupayaan antioksidaan 
yang tinggi terhadap pemerangkapan radikel bebas. Pada kupekatan 1mg/mL, ekstrak 
merencat  aktiviti LPL secara berbeza dengan MCFE menunjukkan kesan perencatan 
paling tinggi (21.4±2.3%), diukuti  CAE (16.3±1.1 %) dan MCE (10.6 ±0.6%). Pada 
kepetan 0.25 mg/mL CAE, MCFE and MCE  menunjukkan pencegehan aktiivti lipase 
pankreatik tinggi pada masing masing ( 31.1%), (29.7%), (21.5 %) . MCE menunjukkan 
kesan perencatan paling keatas pengandaan sel dan pembezaan preadiposites. Selepas 72 
jam, MCE didapati lebih toksik dengan LC50 1.6 mg/mL diikuti oleh CAE dengan nilai 
LC 50 dan 2.4 mg/mL dan MCFE mempunyai kesan sitotosik paling rendah dengan nilai 
LC 50 4.5 mg/mL. Keputusan selepas 48 jam menunjukkan MCE menpunyai kesan 
perencatan  paling tinggi Perencatan paling tinggi 74.7 ± 5.41 5 daripada kawalan berlaku 
pada kepekatan 0.5 mg/mL. Data daripada kajian menunjukkan MCE boleh memberi 
kesan anti kegemukan dengan mencegah pengendaan dan perbezaan preadiposite dan 
MCFE juga anti LPL dan anti PL  yang tinggi.  
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CHAPTER 1 
 
1 INTRODUCTION  
 
Obesity is a rapidly growing epidemic worldwide, presenting an increase in the risk of 
morbidity and mortality in many countries across the world (World Health Organization, 
2000). It is believed that today, more than 1.1 billions people are overweight worldwide 
and 312 million are classified as obese (Hossain et al., 2007). Complications associated 
with obesity, such as hypertension, hyperlipidemia, diabetes mellitus, cardiovascular 
disease, cancer, metabolic disorders are forcing researchers to come up with long term 
solutions for weight management and control (Ferraro et al., 2002; Mukherjee 2003). 
Unfortunately, Malaysia has not been spared by the escalating problem of obesity. The 
Third National Health and Morbidity Survey (NHMS III, 2001/2002) revealed that 23 % 
of adults were overweight and 14 % were in the obese category (Fatimah et al., 2005). 
Obesity has also been defined as an increased adipose tissue mass which is the result of 
an enlargement in fat cells and/or an increase in their number (Couillard et al., 2000). The 
main cause of obesity is believed to be an imbalance between energy input and energy 
expenditure and weight loss requires a sustained negative energy balance: energy output 
must exceed energy intake (Stunkard, 1996). 
 
Although reduction of caloric intake by diet and increased level of physical activity are 
very well known approaches to lose weight, the needs for drugs and other supplements 
are fast gaining acceptance. Pancreatic lipase (PL) is one of the exocrine enzymes of 
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pancreatic juice that is essential for the digestion of dietary fats in the intestinal lumen. 
Pancreatic lipase fulfills an important function in dietary fats absorption by hydrolyzing 
triglycerides into diglycerides and subsequently into monoglycerides and free fatty acids 
(Winkler et al., 1990). As hydrolysis of dietary triacylglycerol is essential for subsequent 
absorption by enterocytes, inhibition of pancreatic lipase will function by reducing the 
availability of dietary fats calories preventing the assimilation of fats and thus mimic the 
effect of reduced food intake (Mukherjee, 2003).     
 
 Lipoprotein Lipase (LPL) is a non covalent homodimeric protein produces mainly by the 
adipose, heart and muscle tissues (Brunzell et al., 1989). LPL is the enzyme that 
hydrolyses triglycerides (TG) component of circulating lipoprotein, hence ensuring that 
fatty acids are delivered to the tissues. LPL activity in the adipose tissue and muscle will 
determine to what extent ingested lipids are stored or utilized, hence the amount of fat 
deposited in the adipose tissue. Due to this action, LPL is closely related to obesity. It 
was also observed that LPL activity seems relatively high in obese rats (Gamarallage et 
al., (2003) 
 
Lu   and co workers (2006) rewieved that fat tissues are regulated by the number and 
capacity of adipocytes. An increased in the proliferation and differentiation of 
preadipocytes may promote excess fat accumulation in the tissues. A regulation of the 
proliferation and differentiation of preadipocytes could mean control over fat deposition 
in the tissues.  Moreover since the conversion from undifferentiated fibroblast-like 
preadipocytes into mature adipocytes, constitutes the adipocyte life cycle (Rayalam et al., 
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2008), the inhibition of adipocyte differentiation can be used as a control for obesity 
(Okano et al., 1997). 
 
The condition of obesity has also been linked with poor antioxidant status (Ozata et al., 
2002). People with higher Body Mass Index (BMI) have been shown to have high 
oxidative stress in relation to the content of antioxidative compounds and minerals in the 
blood (Reitman et al., 2002).  
 
Tropical countries like Malaysia are very rich in herbs and plants and much research has 
to be done to make maximum use of their benefits. Research in this area is very crucial as 
the use of medication and pharmaceuticals in the management of obesity is highly 
controversial and does not address a long term solution. Momordica charantia, (MC) 
Bitter melon; cucurbitacea family, locally known as “peria katak” is a vegetable 
indigenous to subtropical and tropical regions of South America and Asia. Fruits and 
seeds of this plant have been used since the dawn of time for treatment of diabetes in 
Southeast Asian countries (Platel and Srinivasan, 1997). Centella asiatica (CA) or 
“pegaga” is one of the local herbs that is claimed to possess various physiological effects 
(Zainol et al., 2003).  Centella asiatica  have been known to be used for wound healing, 
memory improvement, treating mental fatigue ( Goh et al., 1995), allergies and cancer, 
especially leukemia (Kan, 1986). Morinda citrifolia L. (MCL) (Rubiaceae), locally 
known as mengkudu, has been used in folk remedies for over 2000 years. All parts of the 
plants, which include fruits, leaves, bark and roots have been shown to contain active 
compounds that have high medicinal values. Medical applications have been reported for 
23 
 
diabetes, antiseptic, hypertension, anticancer and antibiotic properties (Dixon et al., 
1999). These plants are also known to be used as slimming aids by various communities 
in Malaysia.  
 
Hence the objectives of this study were:  
 
1. To determine the total phenolic content, flavonoids content and 
antioxidant activity of extracts of Momordica charantia, Morinda 
citrifolia Fruit and Centella asiatica. 
2. To determine the effects of extracts on Pancreatic lipase and 
Lipoprotein lipase activity. 
3. To determine the effects of extracts on the proliferation and 
differentiation of 3T3-L1 preadipocytes.  
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CHAPTER 2 
 
2. LITERATURE REVIEW 
  
2.1 Obesity and Causes of Obesity 
 
Obesity is a rapidly growing, worldwide epidemic and increases the risk of morbidity, in 
many countries across the world (World Health Organization, 2000). The most common 
definition of obesity is the BMI, calculated as body weight in kilogram divided by the 
square of height in meters. Being overweight is defined as a BMI of 25.0 – 29.9 kgM-2 
and a BMI exceeding 30 kg M-2 is considered as obese. An extreme obesity is defined as 
a BMI of greater than 40 kg M-2(Thompson et al., 2007). Today, more than 65 percent of 
adults in the United States are overweight or obese (National Institutes of Health, 2006). 
Although the problem of Obesity in Malaysia is not as severe as it is in the United States, 
it has been a source of worry lately for the Malaysian Government. Based on the Third 
National Health and Morbidity Survey (NHMS III, 2001/2002) that was carried out 
nationwide, the prevalence of overweight and obesity among adults aged 18 years were 
23 % and 14 % respectively (Fatimah et al., 2005).  Obesity is a major source of concern 
as it is now characterized as a chronic disease (Stunkard, 1999). A chronic disease is 
defined as a disruption of bodily functions that develops slowly, and persists for an 
extended period, often for the life of the affected individual (Butler, 1991). As described 
by Mukherjee (2003), not only obesity is a threat to the general health of the public but is 
also a risk factor for clinical disorders such as hypertension, hyperlipidemia, diabetes 
 
